Literature DB >> 26179958

Biodegradation, biocompatibility, and osteoconduction evaluation of collagen-nanohydroxyapatite cryogels for bone tissue regeneration.

Christiane Laranjo Salgado1,2,3, Liliana Grenho1,2,3, Maria Helena Fernandes4, Bruno Jorge Colaço5, Fernando Jorge Monteiro1,2,3.   

Abstract

Designing biomimetic biomaterials inspired by the natural complex structure of bone and other hard tissues is still a challenge nowadays. The control of the biomineralization process onto biomaterials should be evaluated before clinical application. Aiming at bone regeneration applications, this work evaluated the in vitro biodegradation and interaction between human bone marrow stromal cells (HBMSC) cultured on different collagen/nanohydroxyapatite cryogels. Cell proliferation, differentiation, morphology, and metabolic activity were assessed through different protocols. All the biocomposite materials allowed physiologic apatite deposition after incubation in simulated body fluid and the cryogel with the highest nanoHA content showed to have the highest mechanical strength (DMA). The study clearly showed that the highest concentration of nanoHA granules on the cryogels were able to support cell type's survival, proliferation, and individual functionality in a monoculture system, for 21 days. In fact, the biocomposites were also able to differentiate HBMSCs into osteoblastic phenotype. The composites behavior was also assessed in vivo through subcutaneous and bone implantation in rats to evaluate its tissue-forming ability and degradation rate. The cryogels Coll/nanoHA (30 : 70) promoted tissue regeneration and adverse reactions were not observed on subcutaneous and bone implants. The results achieved suggest that scaffolds of Coll/nanoHA (30 : 70) should be considered promising implants for bone defects that present a grotto like appearance with a relatively small access but a wider hollow inside. This material could adjust to small dimensions and when entering into the defect, it could expand inside and remain in close contact with the defect walls, thus ensuring adequate osteoconductivity.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomimetic material; bone regeneration; collagen; nanohydroxyapatite

Mesh:

Substances:

Year:  2015        PMID: 26179958     DOI: 10.1002/jbm.a.35540

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  5 in total

1.  In vitro and in vivo biocompatibility assessment of free radical scavenging nanocomposite scaffolds for bone tissue regeneration.

Authors:  Krista Dulany; Katie Hepburn; Allison Goins; Josephine B Allen
Journal:  J Biomed Mater Res A       Date:  2019-10-23       Impact factor: 4.396

2.  Development and characterization of poultry collagen-based hybrid hydrogels for bone regeneration.

Authors:  Francisco Fábio Pereira de Souza; Jesús Alberto Pérez-Guerrero; Maria Janaína Paula Gomes; Fábio Lima Cavalcante; Men de Sá Moreira de Souza Filho; Igor Iuco Castro-Silva
Journal:  Acta Cir Bras       Date:  2022-05-13       Impact factor: 1.564

3.  Effects of processing on structural, mechanical and biological properties of collagen-based substrates for regenerative medicine.

Authors:  A Terzi; E Storelli; S Bettini; T Sibillano; D Altamura; L Salvatore; M Madaghiele; A Romano; D Siliqi; M Ladisa; L De Caro; A Quattrini; L Valli; A Sannino; C Giannini
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

4.  Composite Cryogel with Polyelectrolyte Complexes for Growth Factor Delivery.

Authors:  Bolat Sultankulov; Dmitriy Berillo; Sholpan Kauanova; Sergey Mikhalovsky; Lyuba Mikhalovska; Arman Saparov
Journal:  Pharmaceutics       Date:  2019-12-04       Impact factor: 6.321

5.  Biomaterials with Potential Use in Bone Tissue Regeneration-Collagen/Chitosan/Silk Fibroin Scaffolds Cross-Linked by EDC/NHS.

Authors:  Sylwia Grabska-Zielińska; Alina Sionkowska; Ângela Carvalho; Fernando J Monteiro
Journal:  Materials (Basel)       Date:  2021-02-26       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.